Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CVC Capital Partners
Pharma
Recordati to acquire EUSA Pharma for €750m ($845 million)
Recordati has agreed on a price for EUSA Pharma. The Milan-based firm will pay $845 million for EUSA’s portfolio of rare cancer drugs.
Kevin Dunleavy
Dec 3, 2021 11:10am
GSK's consumer health unit draws buyout interest amid spinoff
Oct 12, 2021 11:13am
GSK starts £1B OTC sell-off ahead of Pfizer merger: report
Jun 20, 2019 10:30am
CVC revs up rare disease ambitions with $3.5B Recordati buy
Jul 2, 2018 11:05am